Table 4. Percentage of each group showing reliable decline, reliable improvement or no change for each task at T2 (T3).
|
Chemotherapy group (n=85)
|
Nonchemotherapy group (n=43)
|
Healthy control group (n=49)
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Decline | Improve | Stable | Decline | Improve | Stable | Decline | Improve | Stable | |
| Lettera cancellation | 4 (6) | 2 (2) | 94 (92) | 0 (9) | 5 (5) | 95 (86) | 4 (2) | 4 (4) | 92 (94) |
| AVLT supraspan | 15 (14) | 10 (9) | 75 (77) | 9 (5) | 9 (5) | 82 (90) | 8 (6) | 16 (6) | 76 (88) |
| AVLT total | 12 (12) | 4 (6) | 84 (82) | 9 (16) | 5 (12) | 86 (72) | 6 (8) | 4 (6) | 90 (86) |
| AVLT delayed | 5 (5) | 2 (5) | 93 (90) | 2 (0) | 12 (12) | 86 (88) | 6 (0) | 4 (6) | 90 (94) |
| Complex figure imm.b,c | 5 (5) | 8 (12) | 87 (83) | 12 (2) | 5 (13) | 84 (85) | 4 (4) | 2 (4) | 94 (92) |
| Complex figure del.d | 7 (1) | 7 (12) | 86 (87) | 5 (2) | 2 (2) | 93 (96) | 2 (0) | 4 (6) | 94 (94) |
| Story imm. | 8 (11) | 11 (12) | 81 (77) | 14 (7) | 14 (14) | 72 (79) | 6 (8) | 6 (4) | 88 (88) |
| Story del. | 10 (1) | 15 (8) | 75 (91) | 9 (5) | 9 (5) | 82 (90) | 2 (2) | 4 (4) | 94 (94) |
| Letter/number sequencing | 5 (10) | 3 (5) | 92 (85) | 14 (9) | 0 (2) | 86 (89) | 6 (8) | 8 (4) | 86 (88) |
| Digit span forward | 6 (4) | 3 (2) | 91 (94) | 7 (2) | 0 (5) | 93 (93) | 10 (4) | 2 (4) | 88 (92) |
| Digit span backwards | 2 (5) | 0 (3) | 98 (92) | 7 (5) | 0 (9) | 93 (86) | 8 (2) | 4 (2) | 88 (96) |
| Spatial span forwards | 0 (2) | 3 (18) | 97 (80) | 0 (7) | 5 (9) | 95 (84) | 10 (6) | 4 (0) | 86 (94) |
| Spatial span backwards | 5 (4) | 3 (1) | 92 (95) | 5 (0) | 7 (2) | 88 (98) | 2 (6) | 8 (2) | 90 (92) |
| Stroope,f | 11 (4) | 5 (8) | 84 (88) | 9 (7) | 2 (9) | 88 (84) | 6 (4) | 6 (4) | 88 (92) |
Missing data.
a
Time 3; data missing from one chemotherapy patient and one nonchemotherapy patient.
b
Time 2; data missing from one healthy control.
c
Time 3; data missing from one chemotherapy patient and one healthy control.
d
Time 3; data missing from one chemotherapy patient.
e
Time 2; data missing from one chemotherapy patient and one healthy control.
f
Time 3; data missing from two chemotherapy patients and one healthy control.